 BRISBANE, Calif.--BUSINESS WIRE--Sangamo Therapeutics, Inc. Nasdaq: SGMO, a genomic medicine company, announced today that management will be participating in the following investor conferences: Cowen 42nd Annual Health Care Conference Date: Monday, March 7th at 12:50 p.m. Eastern Time Barclays Global Healthcare Conference Date: Thursday, March 17th at 9:00 a.m. Eastern Time H.C. Wainwright Co. Gene Editing and Therapy Conference 2022 Date: Wednesday, March 30th at 7:00 a.m. Eastern T 